M23-384: A Phase 3 Randomized, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of ABBV-706 versus Standard of Care in Subjects with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
- Title
- A Phase 3 Randomized, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of ABBV-706 versus Standard of Care in Subjects with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
- Principal Investigator
- Almubarak, Mohammed
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Lung Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Rachel Harper
- Clinical Research Specialist
- Phone: +1 304-293-6066
- Email: rachel.harper@hsc.wvu.edu